Gossamer Bio, Inc. (GOSS)

Gossamer Bio Revenue

Gossamer Bio had revenue of $16.96M in the quarter ending March 31, 2026, with 71.45% growth. This brings the company's revenue in the last twelve months to $55.54M, down -55.42% year-over-year. In the year 2025, Gossamer Bio had annual revenue of $48.47M, down -57.74%.

• Revenue (ttm): $55.54M
• Revenue Growth: -55.42%
• P/S Ratio: 0.84
• Revenue / Employee: $342,821
• Employees: 162
• Market Cap: 46.73M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	48.47M	-66.23M	-57.74%
Dec 31, 2024	114.70M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error